Precision Assessment of Platelet Rich Plasma for Joint Preservation
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT03460236
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Knee Osteoarthritis (OA) is a leading cause of premature disability in Veterans who develop knee OA at higher rates and younger ages than the population in general. For those with symptomatic early knee OA, who are years to decades away from meeting clinical indications for knee replacement surgery, knee injections have been a key treatment option. In recent years, platelet rich plasma (PRP) injections have gained increasing attention for improving pain and function in patients with knee OA. Basic science studies also suggest that PRP may also potentially stimulate repair responses to articular cartilage. However, the mechanisms of action of PRP in the treatment of knee OA are unknown. Because autologous blood is used, the PRP composition differs between patients. It is also unknown whether these differences in PRP composition affect clinical outcomes. This study will address these gaps and provide critical new and objective information on PRP treatment effects in Veterans and additional women with early knee OA important to improving clinical use of this new treatment.
Key Dates
- Start date
- Apr 2, 2018
- Status verified
- May 2025
- Primary completion
- Mar 29, 2024
- Completion
- Mar 31, 2024
Study Design
- Enrollment
- 90 participants (actual)
Arms
- Arm: PRPSymptomatic early knee osteoarthritis subjects who have elected to receive PRP treatment.
Primary Outcome Measure
Number of Participants With Successful Knee Pain Improvement Over 6 Months Following PRP Injections [ Time Frame: Baseline to 6 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Palo Alto Health Care System, Palo Alto, CA | Palo Alto | California | 94304-1207 | - |
Find similar trials in Palo Alto, CA
Related Studies
- Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal ConditionsNot Yet Recruiting · R3 Stem Cell · Encino, California
- Adipose-Derived Biocellular Regenerative Therapy for OsteoarthritisRecruiting · Healeon Medical Inc · Valencia, California
- Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing InsertEnrolling By Invitation · MicroPort Orthopedics Inc. · Fremont, California
- The KinematX Midcarpal Total Wrist Arthroplasty RegistryRecruiting · Extremity Medical · Loma Linda, California